Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Administering intraperitoneal chemotherapy using a peritoneal port

L S Doane1

  • 1University of Tennessee Medical Center, Knoxville 37920.

The Nursing Clinics of North America
|December 1, 1993
PubMed
Summary

Totally implanted peritoneal access ports simplify intraperitoneal (IP) chemotherapy for intra-abdominal tumors, particularly ovarian cancer. This approach, supported by skilled nurses, enhances patient quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The port: delivering intraperitoneal chemotherapy in ovarian cancer.

Today's OR nurse·1992
Same author

How to give peritoneal chemotherapy.

The American journal of nursing·1990
See all related articles

Area of Science:

  • Oncology
  • Surgical Oncology
  • Clinical Nursing

Background:

  • Intraperitoneal (IP) chemotherapy delivery to the peritoneal cavity has been revolutionized by subcutaneous access ports linked to Tenckhoff catheters.
  • The development of totally implanted peritoneal access ports has significantly reduced infection risks associated with IP therapy.
  • Treatment regimens no longer necessitate drug drainage post-instillation, simplifying the technical aspects of IP therapy.

Purpose of the Study:

  • To highlight the advancements in IP chemotherapy for intra-abdominal tumors, focusing on ovarian cancer.
  • To emphasize the role of totally implanted peritoneal access ports in improving the safety and efficacy of IP therapy.
  • To underscore the critical contribution of nurses in managing and advancing IP chemotherapy protocols.

Main Methods:

  • Utilizing subcutaneous ports connected to Tenckhoff catheters for IP drug delivery.
  • Implementing treatment regimens that eliminate the need for post-instillation drug drainage.
  • Administering IP chemotherapy in an outpatient setting by trained oncology nurses and physicians.

Main Results:

  • IP chemotherapy, facilitated by access ports, has become an effective treatment for ovarian cancer, especially in patients with small-volume disease post-laparotomy.
  • The use of totally implanted ports has diminished the risk of infection, making the procedure safer.
  • The technical complexity of IP therapy has been reduced, allowing for easier administration.

Conclusions:

  • Totally implanted peritoneal access ports are crucial for the success of IP chemotherapy programs, ensuring safe and reliable access to the peritoneal cavity.
  • Oncology nurses play a pivotal role in the safe management of IP therapy, demonstrating skill in patient assessment and intervention.
  • Continued clinical nursing research is essential for further refining IP therapy administration and improving patient quality of life.

Related Experiment Videos